Citius Oncology Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year Ending	TTM	Sep 30, 2023	Sep 30, 2022
Net Income	-17.48	-12.7	-10.87
Stock-Based Compensation	5.84	1.97	-
Other Operating Activities	0.58	0.58	1.15
Change in Accounts Payable	0.5	1.2	0.18
Change in Other Net Operating Assets	10.56	8.96	9.53
Levered Free Cash Flow	-	4.55	-
Unlevered Free Cash Flow	-	4.55	-
Change in Net Working Capital	-	-10.16	-

Source: S&P Capital IQ. Standard template. Financial Sources.